CTBP2 and acute lymphoblastic leukemia: For example, CTBP2, as the most significantly DEG downregulated in the relapse group, cross-linked NOTCH- and Wnt-signaling pathways in the remission sub-network (Figure 6A), which were closely associated with the development of T-ALL.33